1. Home
  2. INSP vs CRVS Comparison

INSP vs CRVS Comparison

Compare INSP & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

HOLD

Current Price

$41.89

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$11.77

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSP
CRVS
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
INSP
CRVS
Price
$41.89
$11.77
Analyst Decision
Buy
Strong Buy
Analyst Count
16
6
Target Price
$94.00
$30.17
AVG Volume (30 Days)
1.1M
1.7M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
179.43
48.04
EPS
N/A
N/A
Revenue
$82,050,000.00
N/A
Revenue This Year
$8.02
N/A
Revenue Next Year
$8.11
N/A
P/E Ratio
N/A
N/A
Revenue Growth
62.18
N/A
52 Week Low
$38.91
$3.55
52 Week High
$147.03
$26.95

Technical Indicators

Market Signals
Indicator
INSP
CRVS
Relative Strength Index (RSI) 40.08 37.20
Support Level $39.61 $11.42
Resistance Level $44.98 $14.00
Average True Range (ATR) 2.33 0.80
MACD 0.26 -0.08
Stochastic Oscillator 49.92 17.05

Price Performance

Historical Comparison
INSP
CRVS

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: